市场调查报告书
商品编码
1258837
到 2028 年的虾青素市场预测 - 按产品(油、液体、软胶囊、干藻粉或生物质)、来源(天然和合成)、生产技术、应用和地区分列的全球分析Astaxanthin Market Forecasts to 2028 - Global Analysis By Product (Oil, Liquid, Softgel and Dried Algae Meal or Biomass), Source (Natural and Synthetic), Production Technology, Application and By Geography |
根据 Stratistics MRC 的数据,2022 年全球虾青素市场规模将达到 8.642 亿美元,预计到 2028 年将达到 16.516 亿美元,预测期内增长 11.3%。预计以 % 的 CAGR 增长。
虾青素是一种称为类胡萝卜素的分子,存在于某些海洋动植物中。 植物的颜色来自一类称为类胡萝卜素的色素。 藻类中富含作为营养补充剂原料的虾青素。 一些海鲜被虾青素染成红色或粉红色。 虾青素是一种抗氧化剂,有助于降低人体内的氧化水平。 因此,生产商正在使用虾青素生产功能性食品和其他商品,这有望刺激全球市场增长。
根据中国渔业报告,中国仍然是世界上最大的海产品生产国,产量为6549万吨。 据印度品牌资产基金会 (IBEF) 称,印度製药业预计将在美国产生 550 亿美元的销售额。
对有机食品的需求不断增加,这主要是因为消费者认为有机食品比传统食品更安全、更健康。 消费者对有机食品和天然色素的健康益处的认识不断提高,导致人们越来越偏爱天然色素而不是合成色素。 消费者健康意识的增强和对环保产品的偏好不断增长,正在推动市场需求。
虾青素产品的批准指南非常严格。 为了推出一种药物,公司必须遵守众多国家和国际法规。 政府对这些化合物的消费施加的限制和法规阻碍了含有虾青素的食品和饮料的使用,从而延长了这些物质的批准过程。 然而,阻碍市场扩张的因素之一是由于原材料短缺导致的高製造成本。
水产养殖、人类和动物都可以从虾青素作为膳食补充剂中获益。 虾青素因其抗氧化、着色和促进健康的特性而被广泛用于饲料添加剂和医药行业。 越来越多的证据表明,由于虾青素在皮肤生物学中的多种集体功能,它在皮肤病学中具有许多健康益处和重要的膳食补充剂应用。 这些因素正在推动市场的增长。
由于虾青素的杂质含量高,环境、人类和动物都处于严重危险之中。 与植物不同,动物不能自行产生虾青素,因此它们必须从饮食中获取。 此外,由于虾青素是从微藻中提取的,因此成本高且耗时长,这使得天然虾青素的开发极为困难。 因此,杂质污染已成为市场增长的主要挑战。
COVID-19 疫情增加了消费者对含虾青素产品的需求。 由于冠状病毒导致免疫系统减弱,许多医生认为天然虾青素是一种有效的抗氧化和抗炎成分,可加速恢復并增强肠道菌群和患者的整体健康状况。推荐使用 肥胖症的增加也增加了消费者对虾青素食品补充剂的偏好,众所周知,虾青素食品补充剂可以促进新陈代谢并减少消化系统中的毒素。 这对行业环境产生了积极影响。
由于对藻类虾青素的需求不断增加,预计干藻粉或生物质行业将实现有利增长。 如此高的份额是由于其广泛的可用性。 天然来源包括磷虾油和 Xantho-phyllomyces dendrorhous。 在其他配方的生产中使用生物质、对下游加工的需求最少、动物饲料的高可用性以及大规模生产的便利性是该细分市场增长的主要驱动力。这是一个因素。
由于对膳食补充剂中天然虾青素的需求不断增加,而且虾青素比其他食品补充剂具有更好的抗氧化特性,因此预计膳食补充剂行业在预测期内增长最快,预计将以復合年增长率增长。 此外,不健康的生活方式、快速衰老和必需营养素摄入不足正在推动对营养补充剂的需求。
由于活跃消费者的存在,亚太地区预计在预测期内将占据最大的市场份额。 高未满足的需求、虾青素产量的增加、研发支出的增加以及经济的扩张是推动该地区对这些产品需求的主要因素。是一个因素。 此外,城市化进程的加快、可支配收入的增加以及对天然虾青素兴趣的增加预计将推动该地区的市场。
由于与营养和皮肤相关的疾病日益流行,预计北美在预测期内的复合年增长率最高。 预计该市场将受到快速城市化、较高的消费者可自由支配收入水平以及对天然产品日益增长的兴趣的推动。 此外,大量注重健康的人、越来越多地采用营养补充剂以及成熟的化妆品行业是推动该地区市场增长的关键因素。
虾青素市场的主要参与者包括:BASF SE、北京银杏集团、Koninklijke DSM N.V.、Cyanotech Corporation、Atacama Bio Natural Products S.A.、ENEOS Corporation、Algalif Iceland ehf、Fuji Chemical Industry Co., Ltd., Algatech Ltd, Digi Laboratories Ltd., Beijing Gingko Group, DSM NV, JXTG Japan Oil & Energy Co., Ltd., Algaecan Biotech Ltd., Griffon Co., Ltd. and Stanley Black & Decker Inc..
2020 年 10 月,Cyanotech Corporation 推出了 1% 和 2% 浓度的水分散性粉末形式的 BioAstin。 它是一种自由流动型,可以分散在热水和冷水中。
2019 年 5 月,Algatech LTD 推出了一种微胶囊天然虾青素粉,专为视觉和大脑健康而配製。 这将使公司能够响应新的细分市场并增加其在市场上的影响力。
购买此报告的客户将免费获得以下定制之一。
According to Stratistics MRC, the Global Astaxanthin Market is accounted for $864.2 million in 2022 and is expected to reach $1,651.6 million by 2028 growing at a CAGR of 11.3% during the forecast period. A molecule called a carotenoid, astaxanthin is present in some marine plants and animals. Plants receive their colour from a class of pigment called carotenoid. Astaxanthin, which can be used as a source for dietary supplements, is abundant in algae. Some seafood are coloured red or pink by astaxanthin. Antioxidant astaxanthin aids in lowering oxidation levels in the human body. As a result, producers are using astaxanthin in the production of functional foods and other goods, which is anticipated to stimulate the growth of the worldwide market.
According to China's Fishery Report, China remained the world's largest seafood producer with a production of 65.49 million metric tons. According to India Brand Equity Foundation (IBEF), Indian pharmaceuticals industry is expected to generate US $55 billion.
Organic food demand is always rising, largely as a result of consumer perceptions that organic food is safer and healthier than conventional food. Due to growing consumer awareness of organic products and the advantages of natural food colours for health, natural food colours are increasingly preferred over synthetic food colours. Consumers increasing health awareness and increased preference for environmentally friendly items are fueling market demand.
Astaxanthin product approval guidelines are very strict. To release their drug, companies must abide by numerous national and international regulations. The use of food and beverages containing astaxanthin has been impeded by government-imposed restrictions and regulations regarding the intake of these compounds, which prolong the approval process of these substances. However, one of the factors impeding market expansion is the high production cost caused by the scarcity of raw materials.
Aquaculture, humans, and animals can all benefit from astaxanthin as a nutritional supplement. Astaxanthin has been widely employed in feed additives and the medical industry because of its antioxidant, colouring, and health-promoting properties. There is mounting evidence that astaxanthin, because of its diverse collective functions in skin biology, offers a number of health benefits and important nutraceutical uses in dermatology. These factors are propelling the growth of the market.
The environment, people, and animals are all in grave peril from adulterated astaxanthin. Animals, unlike plants, cannot generate astaxanthin on their own and must consume it through diet. Furthermore, due to its expensive and labor-intensive production procedure from microalgae, natural astaxanthin may be extremely difficult to develop. Thus, adulteration poses a significant challenge to the growth of the market.
The COVID-19 epidemic increased consumer demand for astaxanthin-containing goods. Many medical professionals recommended using natural astaxanthin since it is an effective anti-oxidant and anti-inflammatory ingredient that speeds up recovery and boosts patients' gut and overall health as a result of the corona virus' weakening effects on immune systems. Also, the rising prevalence of obesity increased consumer preference for astaxanthin food supplements, which are known to promote metabolism and decrease toxins in the digestive system. This had a favourable impact on the industry environment.
The dried algae meal or Biomass segment is estimated to have a lucrative growth, due to the growing demand for algal astaxanthin. Such a high share is due to its wide availability. Few of its natural sources include Krill oil, and Xantho-phyllomyces dendrorhous. The use of biomass for the production of other formulations, the necessity of minimal downstream processing, higher use as animal feed, and convenient bulk production are some key factors driving the segment's growth.
The nutraceuticals segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the increased demand for natural astaxanthin in nutritional products and better antioxidant properties of astaxanthin than other available food supplements. In addition, unhealthy lifestyles, a rapidly aging population, and insufficient intake of essential nutrients are propelling the demand for nutraceuticals.
Asia Pacific is projected to hold the largest market share during the forecast period owing to the presence of highly proactive consumers. High unmet demands, rising astaxanthin production in the area, rising R&D spending, and economic expansion are some of the main factors driving up demand for these items in the area. Also, it is projected that rising urbanisation, high disposable income, and rising interest in natural astaxanthin will boost the market in this region.
North America is projected to have the highest CAGR over the forecast period, owing to the increasing prevalence of nutrition & skin-related diseases. The market is expected to be driven by rapid urbanisation, high consumer discretionary income levels, and rising interest in natural products. Furthermore, a large number of health-conscious people, an increase in the adoption of nutraceuticals, and a well-established cosmeceutical industry are some of the major factors accelerating market growth in the region.
Some of the key players profiled in the Astaxanthin Market include: BASF SE, Beijing Ginko Group, Koninklijke DSM N.V., Cyanotech Corporation, Atacama Bio Natural Products S.A., ENEOS Corporation, Algalif Iceland ehf, Fuji Chemical Industries Co., Ltd, Algatech Ltd, Divi Laboratories Ltd., Beijing Gingko Group, DSM NV., JXTG Nippon Oil & Energy Corporation, Algaecan Biotech Ltd, Griffon Corporation Inc. and Stanley Black & Decker Inc.
In October 2020, Cyanotech Corporation launched a water-dispersible powder form of BioAstin, available in both 1% and 2% concentrations. It is free-flowing and dispersible in either hot or cold water.
In May 2019, Algatech LTD has launched a micro-encapsulated natural astaxanthin powder that is formulated for vision and brain health. This would help the company cater to new segments, strengthening its market presence.
All the customers of this report will be entitled to receive one of the following free customization options: